$BSX
BOSTON SCIENTIFIC CORP

2011 Q4 Form 10-Q Financial Statement

#000088572511000055 Filed on November 08, 2011

View on sec.gov

Income Statement

Concept 2011 Q4 2011 Q3 2010 Q3
Revenue $1.848B $1.874B $1.916B
YoY Change -7.69% -2.19% -5.38%
Cost Of Revenue $687.0M $680.0M $623.0M
YoY Change -1.43% 9.15% -8.38%
Gross Profit $1.161B $1.194B $1.293B
YoY Change -11.03% -7.66% -3.87%
Gross Profit Margin 62.82% 63.71% 67.48%
Selling, General & Admin $618.0M $629.0M $634.0M
YoY Change -9.25% -0.79% -4.66%
% of Gross Profit 53.23% 52.68% 49.03%
Research & Development $231.0M $229.0M $230.0M
YoY Change 2.67% -0.43% -10.85%
% of Gross Profit 19.9% 19.18% 17.79%
Depreciation & Amortization $96.00M $75.00M $72.00M
YoY Change -27.27% 4.17% -42.86%
% of Gross Profit 8.27% 6.28% 5.57%
Operating Expenses $933.0M $1.020B $1.042B
YoY Change -10.29% -2.11% -0.67%
Operating Profit $228.0M $174.0M $251.0M
YoY Change -13.96% -30.68% -15.2%
Interest Expense -$70.00M $62.00M $91.00M
YoY Change -35.19% -31.87% -200.0%
% of Operating Profit -30.7% 35.63% 36.25%
Other Income/Expense, Net -$1.000M -$63.00M -$88.00M
YoY Change -91.67% -28.41% 2100.0%
Pretax Income $100.0M $111.0M $163.0M
YoY Change -56.33% -31.9% -470.45%
Income Tax -$7.000M -$31.00M -$27.00M
% Of Pretax Income -7.0% -27.93% -16.56%
Net Earnings $107.0M $142.0M $190.0M
YoY Change -54.66% -25.26% -302.13%
Net Earnings / Revenue 5.79% 7.58% 9.92%
Basic Earnings Per Share $0.09 $0.13
Diluted Earnings Per Share $72.30K $0.09 $0.12
COMMON SHARES
Basic Shares Outstanding 1.482B shares 1.514B shares 1.520B shares
Diluted Shares Outstanding 1.524B shares 1.529B shares

Balance Sheet

Concept 2011 Q4 2011 Q3 2010 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $267.0M $276.0M $624.0M
YoY Change 25.35% -55.77% -54.82%
Cash & Equivalents $267.0M $276.0M $624.0M
Short-Term Investments
Other Short-Term Assets $661.0M $728.0M $692.0M
YoY Change -44.36% 5.2% -42.72%
Inventory $931.0M $972.0M $923.0M
Prepaid Expenses
Receivables $1.246B $1.237B $1.317B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.105B $3.213B $3.556B
YoY Change -14.11% -9.65% -28.34%
LONG-TERM ASSETS
Property, Plant & Equipment $1.670B $1.684B $1.712B
YoY Change -1.59% -1.64% -1.1%
Goodwill $9.761B $9.769B
YoY Change -4.17%
Intangibles $6.473B $6.564B
YoY Change 2.05%
Long-Term Investments $7.000M
YoY Change 0.0%
Other Assets $281.0M $272.0M $335.0M
YoY Change -2.09% -18.81% 34.54%
Total Long-Term Assets $18.19B $18.29B $18.93B
YoY Change -1.77% -3.39% -10.99%
TOTAL ASSETS
Total Short-Term Assets $3.105B $3.213B $3.556B
Total Long-Term Assets $18.19B $18.29B $18.93B
Total Assets $21.29B $21.50B $22.49B
YoY Change -3.79% -4.38% -14.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $203.0M $256.0M $195.0M
YoY Change 10.33% 31.28% -13.33%
Accrued Expenses $1.327B $1.296B $1.604B
YoY Change -18.39% -19.2% -34.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.000M $4.000M $904.0M
YoY Change -99.21% -99.56% 253.13%
Total Short-Term Liabilities $1.807B $1.887B $2.955B
YoY Change -30.74% -36.14% -6.96%
LONG-TERM LIABILITIES
Long-Term Debt $4.257B $4.259B $5.133B
YoY Change -13.72% -17.03% -11.1%
Other Long-Term Liabilities $2.008B $1.981B $1.436B
YoY Change 22.07% 37.95% -22.34%
Total Long-Term Liabilities $2.008B $1.981B $6.569B
YoY Change 22.07% -69.84% -13.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.807B $1.887B $2.955B
Total Long-Term Liabilities $2.008B $1.981B $6.569B
Total Liabilities $3.815B $3.868B $11.45B
YoY Change -10.32% -66.21% -11.48%
SHAREHOLDERS EQUITY
Retained Earnings -$4.381B -$4.488B
YoY Change -9.15%
Common Stock $16.36B $16.33B
YoY Change 0.72%
Preferred Stock
YoY Change
Treasury Stock (at cost) $492.0M $192.0M
YoY Change
Treasury Stock Shares 81.95M shares
Shareholders Equity $11.35B $11.52B $11.04B
YoY Change
Total Liabilities & Shareholders Equity $21.29B $21.50B $22.49B
YoY Change -3.79% -4.38% -14.27%

Cashflow Statement

Concept 2011 Q4 2011 Q3 2010 Q3
OPERATING ACTIVITIES
Net Income $107.0M $142.0M $190.0M
YoY Change -54.66% -25.26% -302.13%
Depreciation, Depletion And Amortization $96.00M $75.00M $72.00M
YoY Change -27.27% 4.17% -42.86%
Cash From Operating Activities $349.0M $366.0M -$126.0M
YoY Change -22.27% -390.48% -126.03%
INVESTING ACTIVITIES
Capital Expenditures -$84.00M -$69.00M -$79.00M
YoY Change 31.25% -12.66% -18.56%
Acquisitions
YoY Change
Other Investing Activities $26.00M $10.00M $0.00
YoY Change -113.07% -100.0%
Cash From Investing Activities -$58.00M -$59.00M -$79.00M
YoY Change -77.95% -25.32% -15.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $192.0M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -301.0M -179.0M 14.00M
YoY Change -49.58% -1378.57% -106.8%
NET CHANGE
Cash From Operating Activities 349.0M 366.0M -126.0M
Cash From Investing Activities -58.00M -59.00M -79.00M
Cash From Financing Activities -301.0M -179.0M 14.00M
Net Change In Cash -10.00M 128.0M -191.0M
YoY Change -97.57% -167.02% -203.24%
FREE CASH FLOW
Cash From Operating Activities $349.0M $366.0M -$126.0M
Capital Expenditures -$84.00M -$69.00M -$79.00M
Free Cash Flow $433.0M $435.0M -$47.00M
YoY Change -15.59% -1025.53% -108.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
bsx Expected Completion Of Activities Under2011 Restructuring Plan Months
ExpectedCompletionOfActivitiesUnder2011RestructuringPlanMonths
P24M
CY2011Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1237000000 USD
CY2010Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1320000000 USD
CY2011Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
256000000 USD
CY2010Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
184000000 USD
CY2010Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1445000000 USD
CY2011Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1341000000 USD
CY2010Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1062000000 USD
CY2011Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1076000000 USD
CY2010Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1626000000 USD
CY2011Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1296000000 USD
CY2011Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1642000000 USD
CY2010Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1471000000 USD
CY2011Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-132000000 USD
CY2010Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-129000000 USD
CY2011Q3 us-gaap Acquired Finite Lived Intangible Asset Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetWeightedAverageUsefulLife
7.4 years
CY2010Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16232000000 USD
CY2011Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16318000000 USD
CY2010Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
83000000 USD
CY2011Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
75000000 USD
CY2011Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
97000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
381000000 USD
CY2010Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
129000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
325000000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9200000 shares
us-gaap Asset Impairment Charges
AssetImpairmentCharges
718000000 USD
CY2010Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1882000000 USD
CY2011Q3 us-gaap Assets
Assets
21502000000 USD
CY2010Q4 us-gaap Assets
Assets
22128000000 USD
CY2010Q4 us-gaap Assets Current
AssetsCurrent
3615000000 USD
CY2011Q3 us-gaap Assets Current
AssetsCurrent
3213000000 USD
CY2011Q3 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
5000000 USD
CY2010Q4 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
576000000 USD
CY2011Q3 us-gaap Assets Held For Sale Property Plant And Equipment
AssetsHeldForSalePropertyPlantAndEquipment
3000000 USD
CY2010Q4 us-gaap Assets Held For Sale Property Plant And Equipment
AssetsHeldForSalePropertyPlantAndEquipment
5000000 USD
CY2011Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
911000000 USD
CY2010Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
919000000 USD
CY2011Q1 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
0 USD
CY2011Q3 us-gaap Business Acquisition Purchase Price Allocation Amortizable Intangible Assets
BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets
97000000 USD
CY2011Q3 us-gaap Business Acquisition Purchase Price Allocation Assets Acquired Liabilities Assumed Net
BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet
712000000 USD
CY2011Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q3 us-gaap Business Acquisition Purchase Price Allocation Deferred Income Taxes Asset Liability Net
BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet
-124000000 USD
CY2011Q3 us-gaap Business Acquisition Purchase Price Allocation Goodwill Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillAmount
271000000 USD
CY2011Q3 us-gaap Business Acquisition Purchase Price Allocation Intangible Assets Not Amortizable
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable
468000000 USD
CY2010Q4 us-gaap Business Combination Assets And Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized
71000000 USD
CY2011Q3 us-gaap Business Combination Assets And Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized
376000000 USD
CY2011Q1 us-gaap Business Combination Assets And Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized
287000000 USD
CY2011Q1 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Fair Value
BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue
55000000 USD
CY2010Q4 us-gaap Cash
Cash
92000000 USD
CY2011Q3 us-gaap Cash
Cash
119000000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213000000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
276000000 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
864000000 USD
CY2010Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
624000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
63000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-240000000 USD
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
0 USD
CY2010Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000 shares
CY2011Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2010Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2011Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1531013482 shares
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1520780112 shares
CY2010Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1520780112 shares
CY2011Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1501013482 shares
CY2010Q4 us-gaap Common Stock Value
CommonStockValue
15000000 USD
CY2011Q3 us-gaap Common Stock Value
CommonStockValue
15000000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
133000000 USD
CY2010Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
110000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
331000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1375000000 USD
CY2010Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
241000000 USD
CY2011Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
263000000 USD
CY2011Q3 us-gaap Cost Method Investments Aggregate Carrying Amount
CostMethodInvestmentsAggregateCarryingAmount
16000000 USD
CY2010Q4 us-gaap Cost Method Investments Aggregate Carrying Amount
CostMethodInvestmentsAggregateCarryingAmount
43000000 USD
us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
5000000 USD
CY2011Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
15000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1999000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1939000000 USD
CY2011Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
680000000 USD
CY2010Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
623000000 USD
CY2011Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
4263000000 USD
CY2010Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
5438000000 USD
CY2011Q3 us-gaap Debt Current
DebtCurrent
4000000 USD
CY2010Q4 us-gaap Debt Current
DebtCurrent
504000000 USD
us-gaap Debt Instrument Decrease Repayments
DebtInstrumentDecreaseRepayments
1250000000 USD
CY2010Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
5654000000 USD
CY2011Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
4667000000 USD
CY2011Q3 us-gaap Deferred Gain Loss On Discontinuation Of Interest Rate Fair Value Hedge
DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge
74000000 USD
CY2010Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
429000000 USD
CY2011Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
409000000 USD
CY2010Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1644000000 USD
CY2011Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1854000000 USD
CY2011Q3 us-gaap Depreciation
Depreciation
75000000 USD
us-gaap Depreciation
Depreciation
221000000 USD
us-gaap Depreciation
Depreciation
215000000 USD
CY2010Q3 us-gaap Depreciation
Depreciation
72000000 USD
CY2010Q4 us-gaap Derecognized Assets Securitized Or Assetbacked Financing Arrangement Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding
DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding
363000000 USD
CY2011Q3 us-gaap Derecognized Assets Securitized Or Assetbacked Financing Arrangement Assets And Any Other Financial Assets Managed Together Principal Amount Outstanding
DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding
387000000 USD
CY2011Q3 us-gaap Derivative Assets
DerivativeAssets
83000000 USD
CY2010Q4 us-gaap Derivative Assets
DerivativeAssets
82000000 USD
CY2011Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
161000000 USD
CY2010Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
189000000 USD
CY2011Q1 us-gaap Disposal Group Deferred Gain On Disposal
DisposalGroupDeferredGainOnDisposal
27000000 USD
CY2011Q3 us-gaap Disposal Group Deferred Gain On Disposal
DisposalGroupDeferredGainOnDisposal
19000000 USD
CY2010 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
340000000 USD
CY2011Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
760000000 USD
CY2011Q1 us-gaap Early Repayment Of Senior Debt
EarlyRepaymentOfSeniorDebt
250000000 USD
us-gaap Early Repayment Of Senior Debt
EarlyRepaymentOfSeniorDebt
1000000000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2010Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2010Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.007
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.384
CY2010Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.166
CY2011Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.279
CY2010Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
436000000 USD
CY2011Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
440000000 USD
CY2010Q3 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
5000000 USD
us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
-22000000 USD
CY2011Q3 us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
-28000000 USD
us-gaap Foreign Currency Cash Flow Hedge Gain Loss Reclassified To Earnings Net
ForeignCurrencyCashFlowHedgeGainLossReclassifiedToEarningsNet
-74000000 USD
CY2011Q3 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
-48000000 USD
CY2011Q3 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
1872000000 USD
CY2010Q4 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
2398000000 USD
CY2011Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-4000000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-9000000 USD
CY2010Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
3000000 USD
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-8000000 USD
CY2010Q4 us-gaap Goodwill
Goodwill
10186000000 USD
CY2011Q3 us-gaap Goodwill
Goodwill
9769000000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
697000000 USD
CY2010Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
USD
CY2011Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1817000000 USD
CY2011Q3 us-gaap Gross Profit
GrossProfit
1194000000 USD
CY2011Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
697000000 USD
us-gaap Gross Profit
GrossProfit
3775000000 USD
CY2010Q3 us-gaap Gross Profit
GrossProfit
1293000000 USD
us-gaap Gross Profit
GrossProfit
3865000000 USD
CY2011Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
9000000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
65000000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
21000000 USD
CY2010Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
5000000 USD
CY2011Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
12000000 USD
CY2010Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
60000000 USD
CY2010Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
163000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
542000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1292000000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
111000000 USD
CY2010Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-27000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-31000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
208000000 USD
CY2011Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-5000000 USD
CY2011Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6564000000 USD
CY2010Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6343000000 USD
us-gaap Interest Expense
InterestExpense
210000000 USD
CY2010Q3 us-gaap Interest Expense
InterestExpense
91000000 USD
CY2011Q3 us-gaap Interest Expense
InterestExpense
62000000 USD
us-gaap Interest Expense
InterestExpense
286000000 USD
CY2011Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
658000000 USD
CY2010Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
622000000 USD
CY2011Q3 us-gaap Inventory Net
InventoryNet
972000000 USD
CY2010Q4 us-gaap Inventory Net
InventoryNet
894000000 USD
CY2010Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
177000000 USD
CY2011Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
217000000 USD
CY2010Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
95000000 USD
CY2011Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
97000000 USD
CY2010Q4 us-gaap Land
Land
119000000 USD
CY2011Q3 us-gaap Land
Land
119000000 USD
CY2011Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21502000000 USD
CY2010Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22128000000 USD
CY2010Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2609000000 USD
CY2011Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1887000000 USD
CY2011Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
350000000 USD
CY2010Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
441000000 USD
CY2011Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
130000000 USD
CY2011Q3 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
139000000 USD
CY2010Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
147000000 USD
CY2009Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
294000000 USD
CY2009Q3 us-gaap Litigation Settlement Gross
LitigationSettlementGross
296000000 USD
CY2011Q3 us-gaap Long Term Debt
LongTermDebt
4200000000 USD
CY2010Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4934000000 USD
CY2011Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
4259000000 USD
CY2011Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
2350000000 USD
CY2011Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
USD
CY2011Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1250000000 USD
CY2011Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
600000000 USD
CY2011Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
USD
CY2011Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
USD
CY2011Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
269000000 USD
CY2010Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
588000000 USD
CY2011Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0 claims
CY2011Q1 us-gaap Maturities Of Senior Debt
MaturitiesOfSeniorDebt
250000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
101000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1420000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-217000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
827000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
659000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-124000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-288000000 USD
CY2011Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-63000000 USD
CY2010Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-88000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-192000000 USD
CY2010Q4 us-gaap Notional Amount Of Interest Rate Derivatives
NotionalAmountOfInterestRateDerivatives
0 USD
CY2011Q3 us-gaap Notional Amount Of Interest Rate Derivatives
NotionalAmountOfInterestRateDerivatives
0 USD
CY2011Q1 us-gaap Notional Amount Of Interest Rate Fair Value Hedge Derivatives
NotionalAmountOfInterestRateFairValueHedgeDerivatives
850000000 USD
CY2010Q3 us-gaap Operating Expenses
OperatingExpenses
1042000000 USD
us-gaap Operating Expenses
OperatingExpenses
4869000000 USD
us-gaap Operating Expenses
OperatingExpenses
3041000000 USD
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
1020000000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
174000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1004000000 USD
CY2010Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
251000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
734000000 USD
CY2010Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
740000000 USD
CY2011Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
718000000 USD
CY2011Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
272000000 USD
CY2010Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
287000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-51000000 USD
CY2010Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
34000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
2000000 USD
CY2011Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-44000000 USD
CY2011Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
35000000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-23000000 USD
CY2010Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-114000000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-5000000 USD
CY2010Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
18000000 USD
CY2011Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6000000 USD
CY2011Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
331000000 USD
CY2010Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
295000000 USD
CY2010Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1645000000 USD
CY2011Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1981000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000000 USD
CY2010Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000000 USD
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 USD
us-gaap Payments For Proceeds From Previous Acquisition
PaymentsForProceedsFromPreviousAcquisition
4000000 USD
us-gaap Payments For Proceeds From Previous Acquisition
PaymentsForProceedsFromPreviousAcquisition
USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
192000000 USD
CY2011Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
192000000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
92000000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
201000000 USD
CY2011Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
24000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
370000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
10000000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
209000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
221000000 USD
CY2011Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2010Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2011Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2010Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q3 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
8000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
900000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1250000000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
200000000 USD
CY2011Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2010Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2010Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
230000000 USD
CY2011Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
229000000 USD
CY2010Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
1426000000 USD
CY2011Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
1450000000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28000000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
973000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
200000000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
425000000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
1000000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
2000000 USD
CY2011Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
35000000 USD
CY2009Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
55000000 USD
CY2010Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
43000000 USD
CY2010Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
45000000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
12000000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
22000000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
12000000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4000000 USD
us-gaap Profit Loss
ProfitLoss
334000000 USD
CY2010Q3 us-gaap Profit Loss
ProfitLoss
190000000 USD
CY2011Q3 us-gaap Profit Loss
ProfitLoss
142000000 USD
us-gaap Profit Loss
ProfitLoss
-1301000000 USD
CY2011Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3326000000 USD
CY2010Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3168000000 USD
CY2010Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1697000000 USD
CY2011Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1684000000 USD
CY2010 us-gaap Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
0.02
us-gaap Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
0.025
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
665000000 USD
CY2011Q3 bsx Claims Cross Appealed By Bsc
ClaimsCrossAppealedByBsc
1 claims
CY2011Q3 bsx Claims Deemed Not Invalid
ClaimsDeemedNotInvalid
2 claims
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
425000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
714000000 USD
CY2010Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1529300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1523100000 shares
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1514400000 shares
CY2010Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1519800000 shares
us-gaap Restructuring And Related Cost Cost Incurred To Date
RestructuringAndRelatedCostCostIncurredToDate
296000000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
139000000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
109000000 USD
CY2011Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
29000000 USD
CY2010Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
18000000 USD
us-gaap Restructuring Charges
RestructuringCharges
77000000 USD
us-gaap Restructuring Charges
RestructuringCharges
98000000 USD
CY2010Q3 us-gaap Restructuring Charges
RestructuringCharges
5000000 USD
CY2011Q3 us-gaap Restructuring Charges
RestructuringCharges
22000000 USD
us-gaap Restructuring Charges
RestructuringCharges
207000000 USD
CY2011Q3 us-gaap Restructuring Reserve
RestructuringReserve
60000000 USD
CY2009Q4 us-gaap Restructuring Reserve
RestructuringReserve
22000000 USD
CY2010Q4 us-gaap Restructuring Reserve
RestructuringReserve
55000000 USD
us-gaap Restructuring Reserve Period Expense
RestructuringReservePeriodExpense
77000000 USD
CY2010 us-gaap Restructuring Reserve Period Expense
RestructuringReservePeriodExpense
98000000 USD
CY2009 us-gaap Restructuring Reserve Period Expense
RestructuringReservePeriodExpense
22000000 USD
CY2010 us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
65000000 USD
CY2009 us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
72000000 USD
CY2011Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4488000000 USD
CY2010Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4822000000 USD
us-gaap Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">ASC Update No.&#160;2009-13</font></div><div style="line-height:120%;padding-top:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October&#160;2009, the FASB issued ASC Update No.&#160;2009-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition (Topic 605) - Multiple-Deliverable Revenue Arrangements.</font><font style="font-family:inherit;font-size:10pt;"> Update No.&#160;2009-13 provides principles and application guidance to determine whether multiple deliverables exist, how the individual deliverables should be separated and how to allocate the revenue in the arrangement among those separate deliverables. We adopted prospectively Update No.&#160;2009-13 as of January&#160;1, 2011. The adoption did not have a material impact on our results of operations or financial position for the three or nine months ended September 30, 2011 and is not expected to have a material impact in subsequent periods.</font></div></div>
us-gaap Royalty Expense
RoyaltyExpense
140000000 USD
us-gaap Royalty Expense
RoyaltyExpense
147000000 USD
CY2011Q3 us-gaap Royalty Expense
RoyaltyExpense
36000000 USD
CY2010Q3 us-gaap Royalty Expense
RoyaltyExpense
39000000 USD
CY2011Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1874000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
5804000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
5774000000 USD
CY2010Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1916000000 USD
us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
5560000000 USD
us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
5640000000 USD
CY2011Q3 us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
1796000000 USD
CY2010Q3 us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
1859000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1866000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1897000000 USD
CY2010Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
634000000 USD
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
629000000 USD
CY2011Q3 us-gaap Senior Notes
SeniorNotes
4200000000 USD
CY2010Q4 us-gaap Senior Notes
SeniorNotes
4450000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
122000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
96000000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
9000000 shares
CY2011Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2000000 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10000000 shares
CY2010Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3000000 shares
CY2011Q3 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
1000000000 USD
CY2011Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
37000000 shares
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11296000000 USD
CY2011Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11521000000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1517000000 shares
CY2010Q4 bsx Accrued Contingent Consideration Current
AccruedContingentConsiderationCurrent
9000000 USD
CY2011Q3 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
12000000 USD
CY2010Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
16000000 USD
CY2011Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
30000000 shares
CY2011Q3 us-gaap Treasury Stock Value
TreasuryStockValue
192000000 USD
CY2010Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
965000000 USD
CY2011Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
935000000 USD
CY2010Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
859000000 USD
CY2011Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
830000000 USD
CY2010Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
78000000 USD
CY2011Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
75000000 USD
CY2009Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
71000000 USD
CY2011Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
67000000 USD
CY2010Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
83000000 USD
CY2010Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
72000000 USD
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
17000000 USD
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
1000000 USD
CY2011Q3 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
12000000 USD
CY2010Q3 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
6000000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
9000000 USD
CY2010Q3 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
10000000 USD
CY2011Q3 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
4000000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8900000 shares
CY2010Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9500000 shares
CY2011Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9600000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
shares
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1524000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1517000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1532000000 shares
CY2011Q3 bsx Accrued Contingent Consideration Current
AccruedContingentConsiderationCurrent
8000000 USD
CY2011Q3 bsx Accrued Contingent Consideration Non Current
AccruedContingentConsiderationNonCurrent
368000000 USD
CY2010Q4 bsx Accrued Contingent Consideration Non Current
AccruedContingentConsiderationNonCurrent
62000000 USD
CY2011Q3 bsx Accrued Interest And Penalties Gross
AccruedInterestAndPenaltiesGross
303000000 USD
CY2010Q4 bsx Accrued Interest And Penalties Gross
AccruedInterestAndPenaltiesGross
285000000 USD
bsx Acquisition Related Milestone
AcquisitionRelatedMilestone
USD
CY2010Q3 bsx Acquisition Related Milestone
AcquisitionRelatedMilestone
USD
bsx Acquisition Related Milestone
AcquisitionRelatedMilestone
250000000 USD
CY2011Q3 bsx Acquisition Related Milestone
AcquisitionRelatedMilestone
USD
CY2010Q1 bsx Acquisition Related Milestone
AcquisitionRelatedMilestone
250000000 USD
CY2011Q3 bsx Additional Gi Stent Patent Allegedly Infringed Thompson
AdditionalGiStentPatentAllegedlyInfringedThompson
1 patents
CY2011Q3 bsx Additional Patents Allegedly Infringed By Vena Cava Filters
AdditionalPatentsAllegedlyInfringedByVenaCavaFilters
1 patents
CY2011Q3 bsx Additional Payments Due Under Mdl Settlement
AdditionalPaymentsDueUnderMdlSettlement
0 USD
CY2011Q3 bsx Additional Pulnev Patents Allegedly Infringed
AdditionalPulnevPatentsAllegedlyInfringed
6 patents
CY2011Q3 bsx Aggregate Sum Of Gross Carrying Value Of Intangible Asset Class Less Accumulated Amortization And Any Impairment Charges Attributable To Companys Us Crm Operating Segment
AggregateSumOfGrossCarryingValueOfIntangibleAssetClassLessAccumulatedAmortizationAndAnyImpairmentChargesAttributableToCompanysUsCrmOperatingSegment
3300000000 USD
CY2011Q3 bsx Allowance For Sales Returns Current
AllowanceForSalesReturnsCurrent
29000000 USD
CY2010Q4 bsx Allowance For Sales Returns Current
AllowanceForSalesReturnsCurrent
42000000 USD
CY2011Q1 bsx Amount Placed In Escrow Included In Proceeds From Divestiture Of Business
AmountPlacedInEscrowIncludedInProceedsFromDivestitureOfBusiness
24000000 USD
bsx Amount Released From Escrow
AmountReleasedFromEscrow
10000000 USD
bsx Approximately Period Of Transfer Or Separation Of Certain Manufacturing Facilities
ApproximatelyPeriodOfTransferOrSeparationOfCertainManufacturingFacilities
P24M
CY2011Q3 bsx Business Acquisition Purchse Price Allocation Net Intangible Assets
BusinessAcquisitionPurchsePriceAllocationNetIntangibleAssets
565000000 USD
CY2011Q1 bsx Business Combination Equity Ownership Before Transaction
BusinessCombinationEquityOwnershipBeforeTransaction
11000000 USD
bsx Business Combinations Contingent Consideration Expense Related To Acquisitions Consummated In Current Period
BusinessCombinationsContingentConsiderationExpenseRelatedToAcquisitionsConsummatedInCurrentPeriod
12000000 USD
CY2011Q3 bsx Business Combinations Contingent Consideration Expense Related To Acquisitions Consummated In Current Period
BusinessCombinationsContingentConsiderationExpenseRelatedToAcquisitionsConsummatedInCurrentPeriod
3000000 USD
CY2011Q3 bsx Business Combinations Contingent Consideration Expense Related To Acquisitions Consummated In Prior Periods
BusinessCombinationsContingentConsiderationExpenseRelatedToAcquisitionsConsummatedInPriorPeriods
3000000 USD
bsx Business Combinations Contingent Consideration Expense Related To Acquisitions Consummated In Prior Periods
BusinessCombinationsContingentConsiderationExpenseRelatedToAcquisitionsConsummatedInPriorPeriods
6000000 USD
CY2010Q4 bsx Carrying Value Of Goodwill Prior To Impairment
CarryingValueOfGoodwillPriorToImpairment
1479000000 USD
CY2010Q4 bsx Changes In Fair Value Of Recurring Fair Value Measurements Amount
ChangesInFairValueOfRecurringFairValueMeasurementsAmount
-71000000 USD
CY2011Q3 bsx Changes In Fair Value Of Recurring Fair Value Measurements Amount
ChangesInFairValueOfRecurringFairValueMeasurementsAmount
-376000000 USD
CY2011Q3 bsx Claim Appealed By Cordis
ClaimAppealedByCordis
1 claims
CY2010Q3 bsx Claims Approved For Participation In Multi District Litigation Settlement
ClaimsApprovedForParticipationInMultiDistrictLitigationSettlement
8180 claims
CY2011Q3 bsx Claims Deemed To Be Infringed
ClaimsDeemedToBeInfringed
0 claims
CY2011Q3 bsx Claims Deemed Unenforceable For Inequitable Conduct
ClaimsDeemedUnenforceableForInequitableConduct
2 claims
CY2011Q3 bsx Claims Of Infringement Of Fischell Patents
ClaimsOfInfringementOfFischellPatents
3 claims
bsx Contingent Consideration Payment Related To Prior Period Acquisition
ContingentConsiderationPaymentRelatedToPriorPeriodAcquisition
4000000 USD
bsx Contingent Consideration Payment Related To Prior Period Acquisition
ContingentConsiderationPaymentRelatedToPriorPeriodAcquisition
0 USD
CY2011Q3 bsx Contingent Receivable For Divestiture Of Business
ContingentReceivableForDivestitureOfBusiness
50000000 USD
CY2011Q1 bsx Contribution Commitment Towards Education Program
ContributionCommitmentTowardsEducationProgram
15000000 USD
CY2010Q4 bsx Currency Hedge Contracts Liabilities
CurrencyHedgeContractsLiabilities
2679000000 USD
CY2011Q3 bsx Currency Hedge Contracts Liabilities
CurrencyHedgeContractsLiabilities
2302000000 USD
CY2011Q3 bsx Derivative Lawsuits Dismissed
DerivativeLawsuitsDismissed
3 lawsuits
CY2011Q3 bsx Dismissals For Which Review Was Not Sought By Plaintiffs
DismissalsForWhichReviewWasNotSoughtByPlaintiffs
2 lawsuits
CY2011Q3 bsx Dismissals Supreme Court Declined To Review
DismissalsSupremeCourtDeclinedToReview
2 lawsuits
bsx Effective Tax Rate
EffectiveTaxRate
0.166
bsx Effective Tax Rate
EffectiveTaxRate
0.202
CY2010Q3 bsx Effective Tax Rate
EffectiveTaxRate
0.168
CY2011Q3 bsx Effective Tax Rate
EffectiveTaxRate
0.201
CY2011Q3 bsx Equipment Furniture And Fixtures Gross
EquipmentFurnitureAndFixturesGross
2033000000 USD
CY2010Q4 bsx Equipment Furniture And Fixtures Gross
EquipmentFurnitureAndFixturesGross
1889000000 USD
bsx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdjustment
-18000000 USD
bsx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Contingent Consideration Liability Recorded
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationLiabilityRecorded
287000000 USD
CY2011Q3 bsx Estimated Total Cost To Complete In Process Research And Development Programs Acquired High End Of Range
EstimatedTotalCostToCompleteInProcessResearchAndDevelopmentProgramsAcquiredHighEndOfRange
200000000 USD
CY2011Q3 bsx Estimated Total Cost To Complete In Process Research And Development Programs Acquired Low End Of Range
EstimatedTotalCostToCompleteInProcessResearchAndDevelopmentProgramsAcquiredLowEndOfRange
150000000 USD
CY2010Q4 bsx Gain Loss In Aoci For Effective Portion Of Cash Flow Hedges
GainLossInAociForEffectivePortionOfCashFlowHedges
-71000000 USD
CY2011Q3 bsx Gain Loss In Aoci For Effective Portion Of Cash Flow Hedges
GainLossInAociForEffectivePortionOfCashFlowHedges
-74000000 USD
CY2011Q3 bsx Gain Loss In Aoci For Effective Portion Of Previously Terminated Interest Rate Contracts
GainLossInAociForEffectivePortionOfPreviouslyTerminatedInterestRateContracts
4000000 USD
CY2010Q4 bsx Gain Loss In Aoci For Effective Portion Of Previously Terminated Interest Rate Contracts
GainLossInAociForEffectivePortionOfPreviouslyTerminatedInterestRateContracts
5000000 USD
CY2011Q3 bsx Gain Loss Recognized In Earnings For Previously Terminated Interest Rate Swaps
GainLossRecognizedInEarningsForPreviouslyTerminatedInterestRateSwaps
0 USD
bsx Gain Loss Recognized In Earnings For Previously Terminated Interest Rate Swaps
GainLossRecognizedInEarningsForPreviouslyTerminatedInterestRateSwaps
0 USD
CY2011Q1 bsx Gain On Divestiture Of Business Net Of Tax
GainOnDivestitureOfBusinessNetOfTax
530000000 USD
bsx Gain On Divestitures
GainOnDivestitures
768000000 USD
bsx Gain On Divestitures
GainOnDivestitures
USD
CY2010Q3 bsx Gain On Divestitures
GainOnDivestitures
USD
CY2011Q3 bsx Gain On Divestitures
GainOnDivestitures
8000000 USD
CY2011Q1 bsx Gain On Transactions
GainOnTransactions
38000000 USD
CY2011Q3 bsx Gain Related To Ineffective Portion Of Hedging Relationships
GainRelatedToIneffectivePortionOfHedgingRelationships
5000000 USD
CY2010Q3 bsx Gain Related To Ineffective Portion Of Hedging Relationships
GainRelatedToIneffectivePortionOfHedgingRelationships
0 USD
bsx Gain Related To Ineffective Portion Of Hedging Relationships
GainRelatedToIneffectivePortionOfHedgingRelationships
5000000 USD
bsx Gain Related To Ineffective Portion Of Hedging Relationships
GainRelatedToIneffectivePortionOfHedgingRelationships
0 USD
bsx Goodwill Impairment Loss Net Of Subsequent Adjustment
GoodwillImpairmentLossNetOfSubsequentAdjustment
1817000000 USD
CY2010Q1 bsx Goodwill Implied Fair Value
GoodwillImpliedFairValue
1479000000 USD
bsx Impact Of Certain Receipts Charges
ImpactOfCertainReceiptsCharges
-0.218
bsx Impact Of Certain Receipts Charges
ImpactOfCertainReceiptsCharges
0.209
CY2010Q3 bsx Impact Of Certain Receipts Charges
ImpactOfCertainReceiptsCharges
0.334
CY2011Q3 bsx Impact Of Certain Receipts Charges
ImpactOfCertainReceiptsCharges
0.480
CY2011Q3 bsx Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
44000000 USD
bsx Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
104000000 USD
CY2010Q3 bsx Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
-22000000 USD
bsx Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
-91000000 USD
CY2011Q3 bsx Income Tax Benefits Related To Interest
IncomeTaxBenefitsRelatedToInterest
4000000 USD
CY2010Q3 bsx Income Tax Benefits Related To Interest
IncomeTaxBenefitsRelatedToInterest
3000000 USD
bsx Increase Decrease In Impact Of Certain Receipts Charges
IncreaseDecreaseInImpactOfCertainReceiptsCharges
-0.427
CY2011Q3 bsx Increase Decrease In Impact Of Certain Receipts Charges
IncreaseDecreaseInImpactOfCertainReceiptsCharges
0.146
bsx Increase Decrease In Reported Tax Rate
IncreaseDecreaseInReportedTaxRate
0.391
CY2011Q3 bsx Increase Decrease In Reported Tax Rate
IncreaseDecreaseInReportedTaxRate
-0.113
CY2011Q3 bsx Incremental Tax Liability Asserted By Irs
IncrementalTaxLiabilityAssertedByIrs
154000000 USD
CY2012 bsx Potential Reduction In Unrecognized Tax Benefits Over Next Twelve Months As Result Of Concluding Certain Matters
PotentialReductionInUnrecognizedTaxBenefitsOverNextTwelveMonthsAsResultOfConcludingCertainMatters
30000000 USD
CY2010Q4 bsx Incremental Tax Liability Asserted By Irs
IncrementalTaxLiabilityAssertedByIrs
525000000 USD
CY2011Q3 bsx Initial Gi Stent Patents Allegedly Infringed Pulnev And Hankh Patents
InitialGiStentPatentsAllegedlyInfringedPulnevAndHankhPatents
3 patents
bsx Interest Expense Related To Income Taxes
InterestExpenseRelatedToIncomeTaxes
12000000 USD
bsx Interest Expense Related To Income Taxes
InterestExpenseRelatedToIncomeTaxes
10000000 USD
CY2011Q3 bsx Level Of Excess Fair Value Over Carrying Value For Reporting Units Maximum
LevelOfExcessFairValueOverCarryingValueForReportingUnitsMaximum
0.15
CY2011Q3 bsx Level Of Excess Fair Value Over Carrying Value For Reporting Units Minimum
LevelOfExcessFairValueOverCarryingValueForReportingUnitsMinimum
0.08
CY2011Q1 bsx Liabilities Assumed By Strkyer In Divestiture
LiabilitiesAssumedByStrkyerInDivestiture
0 USD
CY2011Q3 bsx Matters Related To Sanjay Israni Shareholder Derivative Complaint Discussed In2010 Annual Report Of Form10 K
MattersRelatedToSanjayIsraniShareholderDerivativeComplaintDiscussedIn2010AnnualReportOfForm10K
3 matters
CY2011Q3 bsx Maximum Amount Of Proceeds From Sale Of Finance Receivables
MaximumAmountOfProceedsFromSaleOfFinanceReceivables
330000000 EUR
CY2011Q3 bsx Maximum Amount Of Proceeds From Sale Of Finance Receivables
MaximumAmountOfProceedsFromSaleOfFinanceReceivables
445000000 USD
bsx Maximum Maturity Of Outstanding Cash Flow Hedges In Months
MaximumMaturityOfOutstandingCashFlowHedgesInMonths
P36M
CY2007Q4 bsx Maximum Potential Payment Related To Mdl Settlement
MaximumPotentialPaymentRelatedToMdlSettlement
240000000 USD
CY2011Q3 bsx Mirowski Patents Deemed Non Infringed
MirowskiPatentsDeemedNonInfringed
2 patents
bsx Net Gain Loss From Foreign Currency Transaction Exposures
NetGainLossFromForeignCurrencyTransactionExposures
-11000000 USD
CY2011Q3 bsx Net Gain Loss From Foreign Currency Transaction Exposures
NetGainLossFromForeignCurrencyTransactionExposures
-12000000 USD
bsx Net Gain Loss From Foreign Currency Transaction Exposures
NetGainLossFromForeignCurrencyTransactionExposures
59000000 USD
CY2010Q3 bsx Net Gain Loss From Foreign Currency Transaction Exposures
NetGainLossFromForeignCurrencyTransactionExposures
43000000 USD
bsx Net Increase Decrease In Effective Tax Rate
NetIncreaseDecreaseInEffectiveTaxRate
-0.036
CY2011Q3 bsx Net Increase Decrease In Effective Tax Rate
NetIncreaseDecreaseInEffectiveTaxRate
0.033
CY2010 bsx Neurovascular Sales As Percentage Of Total2010 Net Sales
NeurovascularSalesAsPercentageOfTotal2010NetSales
4 USD
CY2011Q1 bsx Note Receivable
NoteReceivable
6000000 USD
CY2011Q3 bsx Number Of Misdemeanor Charges
NumberOfMisdemeanorCharges
2 charges
bsx Number Of Reportable Segments
NumberOfReportableSegments
4
CY2010 bsx Number Of Reportable Segments
NumberOfReportableSegments
4
CY2011Q3 bsx Number Of Reporting Units With Material Goodwill At Higher Risk Of Failure Of Step One Of Impairment Test
NumberOfReportingUnitsWithMaterialGoodwillAtHigherRiskOfFailureOfStepOneOfImpairmentTest
4 units
CY2011Q3 bsx Number Of Shares To Be Granted Out Of2003 Ltip
NumberOfSharesToBeGrantedOutOf2003Ltip
0 shares
CY2011Q3 bsx Operating Income Allocated To Reportable Segments
OperatingIncomeAllocatedToReportableSegments
463000000 USD
bsx Operating Income Allocated To Reportable Segments
OperatingIncomeAllocatedToReportableSegments
1612000000 USD
bsx Operating Income Allocated To Reportable Segments
OperatingIncomeAllocatedToReportableSegments
1552000000 USD
CY2010Q3 bsx Operating Income Allocated To Reportable Segments
OperatingIncomeAllocatedToReportableSegments
529000000 USD
CY2010Q4 bsx Other Long Term Liabilities
OtherLongTermLiabilities
374000000 USD
CY2011Q3 bsx Other Long Term Liabilities
OtherLongTermLiabilities
398000000 USD
CY2011Q3 bsx Patent Related To Claim Appealed By Cordis
PatentRelatedToClaimAppealedByCordis
1 patents
CY2011Q3 bsx Patents Allegedly Infringed By Ion
PatentsAllegedlyInfringedByIon
2 patents
CY2011Q3 bsx Patents Allegedly Infringed By Latitude
PatentsAllegedlyInfringedByLatitude
2 patents
CY2011Q3 bsx Patents Allegedly Infringed By Nir Stents
PatentsAllegedlyInfringedByNirStents
2 patents
CY2011Q3 bsx Patents Allegedly Infringed By Promus
PatentsAllegedlyInfringedByPromus
3 patents
CY2011Q3 bsx Patents Allegedly Infringed By Vena Cava Filters
PatentsAllegedlyInfringedByVenaCavaFilters
2 patents
CY2011Q3 bsx Patents Allegedly Infringed By Veriflex
PatentsAllegedlyInfringedByVeriflex
2 patents
CY2011Q3 bsx Patents For Which District Court Reversed Its Unenforceable Finding
PatentsForWhichDistrictCourtReversedItsUnenforceableFinding
2 patents
CY2007Q4 bsx Patient Claims Covered Claim Related To Product Communications
PatientClaimsCoveredClaimRelatedToProductCommunications
8550 claims
bsx Payment Made In Multi District Litigation Settlement
PaymentMadeInMultiDistrictLitigationSettlement
234000000 USD
CY2011Q3 bsx Pending Individual Lawsuits Against Guidant
PendingIndividualLawsuitsAgainstGuidant
10 lawsuits
CY2011Q3 bsx Pending Product Liability Class Action Lawsuits
PendingProductLiabilityClassActionLawsuits
10 lawsuits
CY2011Q3 bsx Percentage Of Warranty Liability Related To Business
PercentageOfWarrantyLiabilityRelatedToBusiness
0.85
CY2011Q3 bsx Plaintiffs Filing Additional Purported Securities Class Actions Suits In Same Court
PlaintiffsFilingAdditionalPurportedSecuritiesClassActionsSuitsInSameCourt
4 plaintiffs
CY2011Q3 bsx Potential Unfiled Claims
PotentialUnfiledClaims
130 claims
CY2010Q4 bsx Prepaid Expenses And Other Current Assets
PrepaidExpensesAndOtherCurrentAssets
183000000 USD
CY2011Q3 bsx Prepaid Expenses And Other Current Assets
PrepaidExpensesAndOtherCurrentAssets
314000000 USD
CY2011Q3 bsx Principal Amount Of Debt Hedged By Interest Rate Derivative Contract
PrincipalAmountOfDebtHedgedByInterestRateDerivativeContract
850000000 USD
CY2011Q1 bsx Proceeds From Divestiture Of Business Excluding Amounts Placed In Escrow
ProceedsFromDivestitureOfBusinessExcludingAmountsPlacedInEscrow
1426000000 USD
CY2011Q3 bsx Proceeds Related To Termination Of Interest Rate Swap Contracts
ProceedsRelatedToTerminationOfInterestRateSwapContracts
80000000 USD
CY2011Q3 bsx Product Liability Class Action Suits Settled
ProductLiabilityClassActionSuitsSettled
2 lawsuits
CY2011Q3 bsx Product Liability Lawsuits Dismissed
ProductLiabilityLawsuitsDismissed
4 lawsuits
CY2011Q1 bsx Purchase Price For Divestiture Of Business
PurchasePriceForDivestitureOfBusiness
1500000000 USD
bsx Restructuring Charges Incurred To Date
RestructuringChargesIncurredToDate
207000000 USD
bsx Restructuring Related Costs Incurred To Date
RestructuringRelatedCostsIncurredToDate
89000000 USD
bsx Restructuring Related Expenses
RestructuringRelatedExpenses
41000000 USD
CY2010Q3 bsx Restructuring Related Expenses
RestructuringRelatedExpenses
13000000 USD
bsx Restructuring Related Expenses
RestructuringRelatedExpenses
32000000 USD
CY2011Q3 bsx Restructuring Related Expenses
RestructuringRelatedExpenses
7000000 USD
bsx Restructuring Related Expenses
RestructuringRelatedExpenses
89000000 USD
CY2011Q1 bsx Reversal Of Bad Debt Expense
ReversalOfBadDebtExpense
20000000 USD
CY2009Q3 bsx Reversal Of Related Accrual
ReversalOfRelatedAccrual
2000000 USD
CY2011Q1 bsx Risk Adjusted Discount Rate For Contingent Consideration High End Of Range
RiskAdjustedDiscountRateForContingentConsiderationHighEndOfRange
0.20
CY2011Q1 bsx Risk Adjusted Discount Rate For Contingent Consideration Low End Of Range
RiskAdjustedDiscountRateForContingentConsiderationLowEndOfRange
0.02
CY2011Q3 bsx Securities Class Action Suits Consolidated
SecuritiesClassActionSuitsConsolidated
5 lawsuits
bsx Segment Reporting Sales From Divested Businesses
SegmentReportingSalesFromDivestedBusinesses
110000000 USD
CY2010Q3 bsx Segment Reporting Sales From Divested Businesses
SegmentReportingSalesFromDivestedBusinesses
79000000 USD
CY2011Q3 bsx Segment Reporting Sales From Divested Businesses
SegmentReportingSalesFromDivestedBusinesses
34000000 USD
bsx Segment Reporting Sales From Divested Businesses
SegmentReportingSalesFromDivestedBusinesses
255000000 USD
CY2011Q3 bsx Total Gi Stent Patents Allegedly Infringed
TotalGiStentPatentsAllegedlyInfringed
10 patents
CY2011Q3 bsx Unamortized Gains On Senior Notes
UnamortizedGainsOnSeniorNotes
2000000 USD
CY2010Q4 bsx Unamortized Gains On Senior Notes
UnamortizedGainsOnSeniorNotes
2000000 USD
CY2010Q4 bsx Unamortized Losses On Senior Notes
UnamortizedLossesOnSeniorNotes
5000000 USD
CY2011Q3 bsx Unamortized Losses On Senior Notes
UnamortizedLossesOnSeniorNotes
4000000 USD
CY2011Q3 bsx Unrealized Gain On Interest Rate Cash Flow Hedges Pretax Aoci
UnrealizedGainOnInterestRateCashFlowHedgesPretaxAoci
7000000 USD
CY2010Q4 bsx Unrealized Gain On Interest Rate Cash Flow Hedges Pretax Aoci
UnrealizedGainOnInterestRateCashFlowHedgesPretaxAoci
8000000 USD
CY2011Q3 bsx Wright And Falotico Patents Owned By Johnson Johnson And Cordis
WrightAndFaloticoPatentsOwnedByJohnsonJohnsonAndCordis
4 patents
CY2011Q1 bsx Years Of Probation
YearsOfProbation
3 years
CY2011Q1 bsx Years We Committed To Contribute To Close Gap Program
YearsWeCommittedToContributeToCloseGapProgram
3 years
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2011
dei Document Period End Date
DocumentPeriodEndDate
2011-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000885725
CY2011Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1481505741 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
BOSTON SCIENTIFIC CORPORATION

Files In Submission

Name View Source Status
0000885725-11-000055-index-headers.html Edgar Link pending
0000885725-11-000055-index.html Edgar Link pending
0000885725-11-000055.txt Edgar Link pending
0000885725-11-000055-xbrl.zip Edgar Link pending
bsx-20110930.xml Edgar Link completed
bsx-20110930.xsd Edgar Link pending
bsx-20110930_cal.xml Edgar Link unprocessable
bsx-20110930_def.xml Edgar Link unprocessable
bsx-20110930_lab.xml Edgar Link unprocessable
bsx-20110930_pre.xml Edgar Link unprocessable
exhibit106-q3201110xq.htm Edgar Link pending
exhibit311-q3201110xq.htm Edgar Link pending
exhibit312-q3201110xq.htm Edgar Link pending
exhibit321-q3201110xq.htm Edgar Link pending
exhibit322-q3201110xq.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
q32011form10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending